SCHEMBL6905573

SCHEMBL6905573

CCC(=O)NCC(=O)Nc1ccccc1O

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 1/20 0.50
GAA P10253 5/20 0.49
KMT2A Q03164 5/20 0.49
MAPT P10636 4/20 0.49
RAB9A P51151 4/20 0.49
MEN1 O00255 3/20 0.49
PKM P14618 1/20 0.49
KDM4E B2RXH2 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
NPC1 O15118 3/20 0.46
LMNA P02545 1/20 0.46
TP53 P04637 1/20 0.46
HTT P42858 1/20 0.46
ALDH1A1 P00352 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
MAPK1 P28482 2/20 0.46
HPGD P15428 1/20 0.46
NFKB1 P19838 1/20 0.46
NFKB2 Q00653 1/20 0.46
RELA Q04206 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL860003 0.88 KDM1A (0.57) KDM1AGAAKMT2AMAPTRAB9A
SCHEMBL6907619 0.85 GAA (0.51) KDM1AGAAKMT2AMAPTRAB9A
Formic Acid SCHEMBL28311850 0.81 GAA (0.51) KDM1AGAAKMT2AMAPTRAB9A
SCHEMBL24074374 0.81 ALDH1A1 (0.51) GAAKMT2ARAB9AMEN1PKM
Benzoic Acid SCHEMBL28069719 0.79 RAB9A (0.51) KDM1AGAAKMT2AMAPTRAB9A
SCHEMBL10202305 0.78 KDM1A (0.55) KDM1AGAAKMT2AMAPTRAB9A
SCHEMBL13416408 0.78 KDM1A (0.68) KDM1AGAAKMT2AMAPTRAB9A
SCHEMBL6908849 0.77 MAPT (0.66) GAAKMT2AMAPTRAB9AMEN1
SCHEMBL5536448 0.77 MAPK1 (0.69) KDM1AGAAKMT2AMAPTRAB9A
SCHEMBL29721986 0.77 MAPK1 (0.69) KDM1AGAAKMT2AMAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6824786-B2 TOPICAL APPLYING COSMETIC YU RUEY J (US) 2004-11-30 US claimed
US-20030108496-A1 Compositions comprising phenyl-glycine derivatives YU RUEY J (US) 2003-06-12 US claimed
US-6824786-B2 TOPICAL APPLYING COSMETIC YU RUEY J (US) 2004-11-30 US disclosed
EP-1455734-A1 COMPOSITIONS COMPRISING PHENYL-GLYCINE DERIVATIVES Yu, Ruey J., Dr. (US) 2004-09-15 EP disclosed
US-20030108496-A1 Compositions comprising phenyl-glycine derivatives YU RUEY J (US) 2003-06-12 US disclosed
WO-2003045338-A1 COMPOSITIONS COMPRISING PHENYL-GLYCINE DERIVATIVES YU RUEY J (US) 2003-06-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030108496-A1 Compositions comprising phenyl-glycine derivatives GRHPR, ARL1, SUCLG1 KDM1A 1517/4885GAA 1037/4885KMT2A 1750/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.